Abbvie Inc

Johnson & Johnson on Tuesday reported adjusted earnings and revenue that topped Wall Street's expectations, and lifted its full-year guidance as sales in the company's pharmaceutical and medical devices businesses surged.It marks…

A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020.George Frey | ReutersA federal judge on Friday declined to block the Biden administration from implementing…

Merck & Co. Inc.'s Januvia brand medication, used to treat Type 2 diabetes.Daniel Acker | Bloomberg | Getty ImagesMedicare is poised to directly negotiate drug prices with the pharmaceutical industry this fall for the first time in the…

The U.S. Chamber of Commerce seal is displayed during restoration at the headquarters in Washington, D.C.Andrew Harrer | Bloomberg | Getty ImagesThe U.S. Chamber of Commerce on Wednesday asked a federal judge in Ohio to block Medicare's new…

Hepatitis C virusBSIP | UIG | Getty ImagesThe overwhelming majority of people in the U.S. who have tested positive for hepatitis C have not been cured due to the high cost of oral antiviral treatments and obstacles imposed by insurance…

Chief Executive Officers of pharmaceutical companies testify before the Senate Finance Committee on "Drug Pricing in America: A Prescription for Change, Part II" February 26, 2019 in Washington, DC. From left to right are Richard A.…

(L-R) Richard A. Gonzalez, chairman and CEO of AbbVie Inc., Pascal Soriot, executive director and CEO of AstraZeneca, Giovanni Caforio, chairman of the board and CEO of Bristol-Myers Squibb Co., Jennifer Taubert, executive vice president…

The Health and Human Services Department plans to publish in September a list of 10 drugs covered by Medicare that it will target for price negotiations, the first phase in a long awaited effort to cut costs for seniors.HHS officials, in a…

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Friday's key moments. The 2-year Treasury remains the right buy When to buy our chip plays Quick mentions: TJX,…

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Wednesday's key moments. We're letting our stocks run on Fed day Companies with pricing power are winners here…